BNTX

BioNTech SE ADR

May 18 • 04:00PM ET

88.85

-0.70 -0.78 %

Healthcare • Biotechnology • Germany • Large • NASD

May 15, 4:20 PMBioNTech shareholders approve all 2026 AGM agenda items, appoint Helmut Jeggle Supervisory Board Chairman

Peers: MRNA NVAX REGN INCY BIIB ALNY VRTX GILD AMGN EXEL

| Held by: FBT IBB TCAF FNDF ARKG SPDW BBH BBEU IDNA QQQJ

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-5.87	Insider Own	0.37%	Shs Outstand	252.88M	Perf Week	-4.81%
Market Cap	22.47B	Forward P/E	-	EPS next Y	-5.52	Insider Trans	-5.07%	Shs Float	251.94M	Perf Month	-13.67%
Enterprise Value	5.95B	PEG	-	EPS next Q	-2.40	Inst Own	19.51%	Short Float	0.88%	Perf Quarter	-16.95%
Income	-1.45B	P/S	6.88	EPS this Y	1.88%	Inst Trans	2.39%	Short Ratio	1.95	Perf Half Y	-14.47%
Sales	3.26B	P/B	1.04	EPS next Y	-3.02%	ROA	-6.14%	Short Interest	2.22M	Perf YTD	-6.67%
Book/sh	85.19	P/C	1.33	EPS next 5Y	6.22%	ROE	-6.90%	52W High	124.00 -28.35%	Perf Year	-4.23%
Cash/sh	66.69	P/FCF	18.25	EPS past 3/5Y	- -	ROIC	-6.64%	52W Low	79.52 11.73%	Perf 3Y	-15.34%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-43.74% 42.57%	Gross Margin	73.25%	Volatility	2.35% 3.64%	Perf 5Y	-53.71%
Dividend TTM	-	EV/Sales	1.82	EPS Y/Y TTM	-71.78%	Oper. Margin	-28.20%	ATR (14)	3.53	Perf 10Y	-
Dividend Ex-Date	Jun 02, 2022	Quick Ratio	8.74	Sales Y/Y TTM	10.01%	Profit Margin	-44.38%	RSI (14)	34.35	Recom	1.50
Dividend Gr. 3/5Y	- -	Current Ratio	8.80	EPS Q/Q	-35.14%	SMA20	-9.56%	Beta	1.34	Target Price	129.53
Payout	-	Debt/Eq	0.02	Sales Q/Q	-28.18%	SMA50	-6.16%	Rel Volume	0.87	Prev Close	89.55
Employees	7807	LT Debt/Eq	0.01	Earnings	May 05 BMO	SMA200	-12.56%	Avg Volume	1.13M	Price	88.85
IPO	Oct 10, 2019	Option/Short	Yes / Yes	EPS/Sales Surpr.	4.35% -34.17%	Trades		Volume	982,951	Change	-0.78%

Date	Action	Analyst	Rating Change	Price Target Change
Feb-02-26	Downgrade	Leerink Partners	Outperform → Market Perform	$113
Jan-16-26	Upgrade	Goldman	Neutral → Buy	$142
Jun-05-25	Reiterated	H.C. Wainwright	Buy	$134 → $145
May-29-25	Initiated	Goldman	Neutral	$110
Mar-13-25	Initiated	Citigroup	Buy	$145
Jan-10-25	Initiated	Truist	Buy	$172
Dec-11-24	Initiated	Wells Fargo	Overweight	$170
Dec-02-24	Reiterated	BMO Capital Markets	Outperform
Nov-19-24	Upgrade	Evercore ISI	In-line → Outperform	$110 → $125
Nov-19-24	Initiated	Berenberg	Buy	$130
Nov-08-24	Upgrade	Goldman	Neutral → Buy	$90 → $137
Sep-24-24	Upgrade	Morgan Stanley	Equal-Weight → Overweight	$93 → $145
Sep-17-24	Upgrade	Jefferies	Hold → Buy	$96 → $150
Sep-16-24	Upgrade	JP Morgan	Underweight → Neutral	$91 → $125
Aug-07-24	Upgrade	Deutsche Bank	Hold → Buy	$95
Aug-02-24	Upgrade	HSBC Securities	Hold → Buy
May-14-24	Initiated	Evercore ISI	In-line	$100
Feb-23-24	Initiated	BMO Capital Markets	Outperform	$127
Jan-05-24	Initiated	Oppenheimer	Perform
Dec-01-23	Downgrade	JP Morgan	Neutral → Underweight	$106 → $99

Show Previous Ratings

May-15-26 04:15PM	BioNTech SE Shareholders Approve All Agenda Items at the Annual General Meeting 2026 (GlobeNewswire)
May-07-26 06:45AM	BioNTech Announces New ADS Repurchase Program (GlobeNewswire)
May-05-26 09:54AM	BioNTech to Slash 25% of Workforce as Losses Widen. The Stock Falls. (Barrons.com)
07:26AM	BioNTech to Close Sites, Cut Quarter of Workforce in Savings Push (The Wall Street Journal)
06:45AM	BioNTech Announces First Quarter 2026 Financial Results and Corporate Update (GlobeNewswire)
06:45AM	Loading…
Apr-21-26 06:45AM	BioNTech to Report First Quarter 2026 Financial Results and Corporate Update on May 5, 2026 (GlobeNewswire) +6.09%
Apr-11-26 07:00AM	BioNTech and DualityBio's Antibody-Drug Conjugate Trastuzumab Pamirtecan Demonstrated Clinically Meaningful Efficacy in Patients with HER2-Expressing, Recurrent Endometrial Cancer (GlobeNewswire)
Mar-24-26 06:45AM	BioNTech Clinical Data at ELCC 2026 Highlight Potential of Differentiated Late-Stage Portfolio in Lung Cancer (GlobeNewswire)
Mar-16-26 04:03PM	Covid Vaccine Maker BioNTech Offers Cheap Biotech Play Given Huge Cash Reserves (Barrons.com)
Mar-15-26 05:05PM	Man's dog was riddled with tumors and dying. He used ChatGPT to design a custom cancer vaccine, stunning researchers (Moneywise)
Mar-11-26 05:55AM	BioNTech price target lowered to $130 from $145 at Citi (TipRanks) +8.28%
Mar-10-26 04:42PM	BioNTech Stock Plunges as Founders Leave. Should You Buy the Dip in BNTX Here? (Barchart) -17.88%
04:20PM	BioNTech Cofounders To Step Down. Stock Crumbles. (Investor's Business Daily)
03:39PM	BioNTech Stock Tanks As Outlook, Founder Exit Rattle Bulls (Benzinga)
03:00PM	BioNTech SE (BNTX) Q4 2025 Earnings Call Highlights: Strategic Advances Amidst Revenue Challenges (GuruFocus.com)
11:01AM	Loading…
11:01AM	Kohl's Q4 sales miss, EV maker NIO reports first quarterly profit (Yahoo Finance Video)
10:01AM	BioNTech Tumbles as Founding Duo Plan Leave to Start New Firm (Bloomberg)
09:24AM	BioNTech Reports Earnings. That's Not Why the Stock Is Down 17%. (Barrons.com)
08:40AM	BioNTech Stock Tumbles As Co-Founders Pivot To New MRNA Venture (Benzinga)
07:40AM	Scientists behind COVID-19 vaccine will depart BioNTech (MarketWatch)
07:18AM	BioNTech Plunges as Drugmaker Swings to a Loss. More Than Earnings Are Weighing on the Stock. (Barrons.com)
06:50AM	BioNTech Cofounders to Leave to Form New Company (The Wall Street Journal)
06:45AM	BioNTech Announces Fourth Quarter and Full Year 2025 Financial Results and Corporate Update (GlobeNewswire)
06:33AM	BioNTech and Co-Founders Announce Plan to Pursue Next-Generation mRNA Innovations in Co-Founders-Led New Company as BioNTech Advances Toward Becoming a Multi-Product Company by 2030 (GlobeNewswire)
Mar-09-26 04:17PM	Oracle, Ulta, Adobe, More Stocks With Earnings This Week (Benzinga)
Mar-05-26 12:37PM	Is BioNTech SE (BNTX) A Good Stock To Buy Now? (Insider Monkey)
Mar-04-26 08:14AM	Moderna's $950 Million Settlement Clears Legal Overhang, Stock Soars (Benzinga)
Feb-25-26 09:00AM	Immuno-Oncology Investments Accelerate as Pipeline Catalysts Multiply in 2026 (PR Newswire)
Feb-24-26 06:45AM	BioNTech to Report Fourth Quarter and Full Year 2025 Financial Results and Corporate Update on March 10, 2026 (GlobeNewswire)
Feb-22-26 09:05AM	Moderna, Coinbase, And Global Payments Are Among the Top 10 Large-Cap Gainers Last Week (Feb. 16-Feb. 20): Are the Others in Your Portfolio? (Benzinga)
11:02AM	Loading…
Feb-20-26 11:02AM	Moderna Faces Lawsuit From BioNTech Over Next-Generation COVID-19 Shot (Benzinga)
Feb-19-26 03:43AM	BioNTech SE (BNTX) Rallying on Solid Oncology Strategy (Insider Monkey)
Feb-18-26 11:20AM	Moderna stock surges as FDA reverses course, agrees to review new flu shot (Yahoo Finance)
Feb-09-26 10:29AM	BMY Up 7.6% Post Q4 Earnings: Should You Buy, Sell or Hold the Stock? (Zacks)
Feb-03-26 11:32AM	Pfizer Stock Slides Despite Q4 Earnings Beat and New Obesity Drug Data (Zacks)
Feb-02-26 09:47AM	Palantir upgraded, Best Buy downgraded: Wall Street's top analyst calls (The Fly)
08:10AM	Should You Buy, Hold, or Sell BMY Stock Ahead of Q4 Earnings? (Zacks)
Jan-31-26 06:09AM	Goldman Sachs Picks 2 Stocks That Let Investors Buy the Dip or Ride the Momentum (TipRanks)
Jan-30-26 08:49AM	Will BMY's Oncology Collaborations Drive Its Next Growth Phase? (Zacks)
07:58AM	Should You Buy, Sell or Hold Pfizer Stock Ahead of Q4 Earnings? (Zacks)
02:07AM	Goldman Sachs Highlights BioNTech's (BNTX) Immuno-Oncology and ADC Pipeline (Insider Monkey)
Jan-28-26 09:15AM	Late-Stage Breakthroughs: How 2026's Top Clinical Platforms Are Redefining Cancer Treatment (PR Newswire)
09:13AM	BioNTech SE (BNTX): A Bull Case Theory (Insider Monkey)
08:00AM	BioNTech Announces Appointment of Kylie Jimenez to Management Board as Chief People Officer (GlobeNewswire)
Jan-27-26 01:35PM	2 Biotech Stocks Set to Rebound in 2026 (Motley Fool)
05:38AM	Pfizers CEO on leading after a moonshotand making deals with Trump (Fortune)
05:32AM	What Are Wall Street Analysts' Target Price for Pfizer Stock? (Barchart)
Jan-22-26 10:28AM	BioNTech (BNTX) Soars 11.8%: Is Further Upside Left in the Stock? (Zacks)
01:03AM	Vaccine makers feel a chill as US Health Secretary Kennedy's rhetoric becomes reality (Reuters)
Jan-20-26 01:41PM	BMY vs GSK: Which Biopharma Giant Has Better Prospects for Now? (Zacks)
Jan-19-26 09:01AM	What to Expect From Pfizer's Non-Oncology Business in Q4? (Zacks)
Jan-16-26 09:32AM	Seagate upgraded, Tractor Supply downgraded: Wall Street's top analyst calls (The Fly)
Jan-14-26 07:59AM	JPM26: BioNTech gears up for multiproduct oncology status by 2030 (Pharmaceutical Technology)
04:04AM	BioNTech Pivots Back to Oncology at JPM Conference, Teases 15 Phase III Readouts and $17B Cash Plan (MarketBeat)
Jan-12-26 06:45AM	BioNTech Provides Strategic Business Update and Outlines 2026 Areas of Focus at 44th Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Jan-09-26 09:16AM	BMY Rallies 17.3% in Six Months: Buy, Sell or Hold the Stock? (Zacks)
Dec-23-25 12:53AM	BioNTech SE (BNTX) Closes the Acquisition of CureVac N.V. (Insider Monkey)
Dec-18-25 04:45AM	BioNTech Closes Acquisition of CureVac N.V. Including Subsequent Offering Period to Strengthen its Unique Position in the mRNA Field (GlobeNewswire)
Dec-15-25 09:00AM	GeoVax Announces British Journal of Haematology Publication Highlighting Superior T-Cell Responses of GEO-CM04S1 in CLL Patients (NewMediaWire)
Dec-11-25 02:03PM	Moderna Sounds the Alarm: Is China About to Seize the Biotech Crown from the U.S.? (GuruFocus.com)
07:44AM	BioNTech SE (BNTX) is a Buy on Lung Cancer Treatment Prospects: Clear Street (Insider Monkey)
Dec-09-25 07:00AM	BioNTech and Bristol Myers Squibb Present First Global Phase 2 Data for PD-L1xVEGF-A Bispecific Antibody Pumitamig Showing Encouraging Efficacy in Advanced Triple-Negative Breast Cancer (GlobeNewswire)
Dec-06-25 03:30PM	BioNTech and OncoC4 Announce Clinically Meaningful Overall Survival Benefit for Selective Treg Modulator Gotistobart in Patients with Previously Treated Squamous Non-Small Cell Lung Cancer (GlobeNewswire)
Dec-03-25 09:01AM	BioNTech Achieves Minimum Condition in CureVac Exchange Offer (GlobeNewswire)
Dec-02-25 09:40AM	Vaccine Stocks Fall After FDA Plans to Impose Stricter Vaccine Rules (Zacks)
Dec-01-25 04:41PM	Moderna Slammed By 'Fear, Confusion' After FDA Alleges Covid Shots Killed 10 (Investor's Business Daily) -5.58%
03:05PM	FDA Plans to Tighten Vaccine Approvals Weigh on These Stocks (Investopedia)
12:35PM	Vaccine stocks take a hit as FDA official points to link between COVID-19 vaccines and rare heart condition in young men (MarketWatch)
12:24PM	Nvidia's Synopsys investment, Disney stock pops on Zootopia 2 (Yahoo Finance Video)
12:09PM	Vaccine makers fall on FDA memo, Bally's wins bid for NYC casino (Yahoo Finance Video)
11:05AM	Moderna and Novavax Stocks Drop as FDA Outlines Stricter Vaccine Approvals (Barrons.com)
10:09AM	Moderna, BioNTech Slammed After FDA Links Covid Shots To 10 Deaths (Investor's Business Daily)
09:59AM	Moderna and Novavax Stocks Drop as FDA Proposes Stricter Vaccine Approvals (Barrons.com)
09:36AM	Moderna Falls as FDA Vows to Impose New Vaccine Requirements (Bloomberg)
Nov-26-25 07:30AM	BioNTech Shares Progress on Exchange Offer for CureVac Shares and Highlights December 3, 2025, at 9:00 a.m. Eastern Time Expiration (GlobeNewswire)
Nov-19-25 09:42PM	Pfizer Is Giving Up on BioNTech. Should You Ditch BNTX Stock Now Too? (Barchart)
Nov-17-25 08:58AM	BMY Stock Down on Discontinuation of ACS Clinical Study With JNJ (Zacks)
Nov-14-25 06:41AM	Pfizer Cuts BioNTech Stake by More Than Half (GuruFocus.com)
Nov-13-25 01:24PM	Pfizer Dumps BioNTech Stake as Obesity Gold Rush Heats Up (GuruFocus.com) -7.00%
06:23AM	CPHI 2025: handprint metric bridges pharma sustainability and economic value (Pharmaceutical Technology)
Nov-05-25 11:41AM	Analyst Report: BioNTech SE (Morningstar Research)
Nov-03-25 02:01PM	BioNTech SE (BNTX) Q3 2025 Earnings Call Highlights: Revenue Growth Amid Strategic Investments (GuruFocus.com)
07:13AM	BioNTech Boosts FY25 Revenue Outlook - Update (RTT News)
06:45AM	BioNTech Announces Third Quarter 2025 Financial Results and Corporate Update (GlobeNewswire)
Oct-30-25 10:32AM	BMY Beats on Q3 Earnings and Sales, Raises 2025 Sales View (Zacks)
09:56AM	Singapore Approves Latest Pfizer/BioNTech COVID-19 Vaccine for All Ages (Insider Monkey)
Oct-28-25 01:25PM	3 Stocks Under $30: Where to Put $1,000 to Work Today (24/7 Wall St.)
07:45AM	BioNTech to Host Innovation Series R&D Day on November 11, 2025 (GlobeNewswire)
Oct-27-25 09:17AM	Should You Buy, Hold, or Sell BMY Stock Ahead of Q3 Earnings? (Zacks)
07:45AM	BioNTech to Report Third Quarter 2025 Financial Results and Corporate Update on November 3, 2025 (GlobeNewswire)
Oct-22-25 06:45AM	BioNTech Commences Public Exchange Offer for All Outstanding Shares of CureVac N.V. (GlobeNewswire)
Oct-20-25 10:15AM	Pfizer's Q3 Non-Oncology Performance: Here's What to Expect (Zacks)
Oct-17-25 08:40AM	Euronext backs German push for single European stock exchange (Euronews)
Oct-14-25 05:27PM	R&D spending now can have big payoffs later for companies (TheStreet)
10:01AM	BMY Slips Below 50-Day SMA: Buy, Sell or Hold the Stock? (Zacks)
Oct-08-25 10:15AM	Healthcare Stocks Are Rising: Here Are 2 With Even More Upside Ahead (Motley Fool)
Oct-02-25 10:32AM	Could MRNA's Upcoming Product Launches Reduce COVID Sales Dependency? (Zacks)
Oct-01-25 06:13PM	Why BioNTech Stock Jumped by Nearly 4% on Wednesday (Motley Fool)
Sep-24-25 09:43AM	BMY Reports Positive Data From a Late-Stage Multiple Myeloma Study (Zacks)
Sep-23-25 06:45AM	BioNTech to Host Second AI Day as an Edition of Its Innovation Series on October 1, 2025 (GlobeNewswire)

BioNTech SE operates as immunotherapy company, which engages therapies for cancer and other serious diseases. Its product pipeline include BNT162b2, BNT161, BNT164, FixVac, iNeST, RiboMabs, CAR-T Cells, TCRs and Next-Gen CP Immunomodulators. The company was founded by Christopher Huber, Oezlem Tuereci, and Ugur Sahin on June 2, 2008 and is headquartered in Mainz, Germany.

Co-FounderDr. Ugur Sahin M.D.

Co-FounderDr. Ozlem Tureci M.D.

CFO & Member of Management BoardMr. Ramon Zapata-Gomez

MDDr. Sierk Potting Ph.D.

Chief Legal & Business Officer and Member of the Management BoardDr. James Timothy Patrick Ryan Ph.D.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Medine GmbH	Officer	May 13 '26	Proposed Sale	93.66	858,209	80,379,855		May 12 06:56 PM
Poetting Sierk	Chief Operating Officer	Apr 22 '26	Sale	110.56	50,000	5,527,960	399,387	Apr 23 04:02 PM
Poetting Sierk	Officer	Mar 11 '26	Proposed Sale	83.89	150,000	12,583,500		Mar 11 08:02 AM
Medine GmbH	Officer	Feb 12 '26	Proposed Sale	109.38	858,209	93,870,900		Feb 12 08:17 AM
Tureci Ozlem	Officer	Nov 28 '25	Proposed Sale	102.70	123,331	12,666,094		Nov 28 07:10 AM
Medine GmbH	Officer	Nov 13 '25	Proposed Sale	111.70	1,114,130	124,448,321		Nov 13 08:23 AM
Jeggle Helmut Wolfgang	Director	Nov 05 '25	Proposed Sale	103.43	150,000	15,514,500		Nov 05 04:52 PM
ATHOS KG	10% Owner	Sep 05 '25	Proposed Sale	112.46	500,000	56,230,000		Sep 05 04:41 PM
Medine GmbH	Officer	Aug 15 '25	Proposed Sale	112.70	1,774,837	200,024,130		Aug 15 08:27 AM
Tureci Ozlem	Officer	Aug 15 '25	Proposed Sale	112.70	185,001	20,849,613		Aug 15 08:22 AM
Jeggle Helmut Wolfgang	Director	Jun 04 '25	Proposed Sale	113.10	150,000	16,965,000		Jun 04 08:31 AM
ATHOS KG	10% Owner	Jun 02 '25	Proposed Sale	110.83	175,000	19,394,800		Jun 02 04:08 PM
ATHOS KG	10% Owner	May 28 '25	Proposed Sale	98.68	500,000	49,340,000		May 28 09:00 AM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

BNTX

BioNTech SE ADR

Upgrade your Finviz experience